Investor bets are shifting between the two biotech firms, Moderna and Exelixis, Inc.
1 report, 1 independent
Updated Sep 2
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Investor bets are shifting between the two biotech firms, Moderna and Exelixis, Inc.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Moderna
American biotechnology company
Related events
- Major pharmaceutical companies face industry-wide pressure from patent cliffs and the need to streamline operations.
- Moderna and DaVita are mentioned in the context of sector strength being driven by biotech innovation.
- Robert Langer co-founded the biotech firm Moderna.
- Moderna and Merck announced a partnership on their mRNA cancer vaccine trial, leading to analyst rating hikes.